Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: HPB (Oxford). 2017 Mar 6;19(5):381–387. doi: 10.1016/j.hpb.2016.10.008

Figure 1.

Figure 1

A: Future remnant liver volume before stage one and before stage two of all ALPPS patients in whom both volumes were available (n=23). B: Future remnant liver volume share before stage one of ALPPS patients (n=17) and before standard resection (n=29) and standardized future remnant liver volume share in ALPPS patients before stage one (n=26) and before resection without ALPPS (n=29). C: Overall survival in the selected high risk controls who underwent standard resection of PHC black curve) and ALPPS patients (grey curve). D: Overall survival following exclusion of 90-day mortality.